Long-term response with everolimus for metastatic renal cell carcinoma refractory to sunitinib-sorafenib sequence
Journal Title: OncoReview - Year 2015, Vol 5, Issue 2
Abstract
We presented a 39-year-old male who developed progressive cancer disease 4 years after nephrectomy due to clear cell carcinoma. He was diagnosed with locally reccurence and metastases to the liver, spleen and abdominal muscles. The patient was treated with sunitinib and then after disease progression – with sorafenib. We observed 18 months of cancer control (TKI-TKI). After second progression everolimus was administered. Third line everolimus therapy helped to achieve durable stable disease with PFS 46 months till now (May 2015). The patient remains in very good performance status with minimal toxicity from the regimen. This case illustrates a long term survival for patients with metastatic renal cell carcinoma, a malignancy with historically poor prognosis. The use of three sequential targeted therapies (TKI – TKI – mTORi) helped to achieve over 5 years or disease control, with rarely seen long-term response to third line treatment (mTORi) – where stabilization is good enough. We discussed therapeutic strategies in metastatic renal cell carcinoma according to the literature and therapeutic possibilities in Poland.
Authors and Affiliations
Joanna Kardas, Agnieszka Buraczewska
Keywords
Related Articles
- EP ID EP67783
- DOI -
- Views 197
- Downloads 0
Advanced or metastatic non-small-cell lung cancer treatment - new Polish goverment regulation
The article presents the non-small-cell lung cancer current treatment recommendations in consideration of Polish government regulation.
Effective treatment of severe hypertensive crisis in 2-year-old child with neuroblastoma
We describe a case of a 2-year-old boy with neuroblastoma and high catecholamine levels which developed a severe hypertensive crisis. An oral propranolol and oral angiotensin-converting enzyme inhibitor were used with a...
Mental disorders in cancer patients - clinical approach
Cancer patient is struggling not only with the primary disease, but also is exposed to emotional states that at unfavorable conditions and heavy burden can lead to depression, increased anxiety, and in consequence cause...
Nuclear medicine diagnostic tools for early detection of myocardial damage in treated breast cancer patients
The most severe side effect in treated patients with breast cancer is treatment-induced cardiotoxicity, leading to chronic heart failure or CAD, and worsening the patient’s quality of life. The early detection and medica...
Recommendations for diagnostics and therapy of gastrointestinal stromal tumors (GIST) in 2010
Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of gastrointestinal tract. Advances in the understanding of the molecular mechanisms of GIST pathogenesis have resulted for last years in the...